Dr Shore on the Importance of a Multidisciplinary Team in Urologic Oncology
Neal Shore, MD, FACS, discusses the importance of a multidisciplinary team in light of recent developments in urologic oncology.
Source: onclive.com
Checkmate 901 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Checkmate 901. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Checkmate 901 Today - Breaking & Trending Today
Dr Bellmunt on the Impact of Treatment With Enfortumab Vedotin Plus Pembrolizumab in Urothelial Cancer
Joaquim Bellmunt, MD, PhD, discusses how the FDA approval of enfortumab vedotin plus pembrolizumab impacts the urothelial cancer treatment paradigm.
Source: onclive.com
The result of the phase 3 CHECKMATE 901 trial which looked at Nivolumab plus gemcitabine-cisplatin versus gemcitabine-cisplatin alone for previously untreated unresectable or metastatic urothelial carcinoma
Dr. Sonpavde discusses the efficacy and safety findings from this randomized, open-label trial enrolling patients with advanced or metastatic urothelial carcinoma who had not received prior systemic chemotherapy.
Source: onclive.com